Apogee Therapeutics Inc.
APGE
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.36B
Close$
$2.02
98.5% downside
Current Fair Value
98.5% downsideOvervalued by 98.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.36 Billion |
|---|---|
| Enterprise Value | $8.26 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.22 |
| Beta | 0.34 |
| Outstanding Shares | 75,443,496 |
Return
| Return on Equity | -24.64% |
|---|---|
| Return on Assets | -22.04% |
| Return on Invested Capital | -23.88% |
Valuation & Multiples
| P/E Ratio | -31.12 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 9.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -26.64 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-1.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-1.14
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.3137▲ 390.71% |
|---|---|
| Total Calls | 270,000▼ 69.46% |
| Total Puts | 1,164,700▲ 223.98% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 97.74%▼ 15.74% |
|---|---|
| Total Invested | $9.02B▲ 35.93% |
| Investors Holding | 310▲ 70.00% |
ESG Score
No data